Crossmark

Comment on “Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Dipeptidyl Peptidase-4 Inhibitor on the Risks of New-Onset Atrial Fibrillation, Stroke and Mortality in Diabetic Patients”

Crossref DOI link: https://doi.org/10.1007/s10557-023-07527-z

Published Online: 2023-11-27

Published Print: 2024-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lai, Shih-Wei https://orcid.org/0000-0002-7420-1572
License Information

Text and Data Mining valid from 2023-11-27

Version of Record valid from 2023-11-27
More Information

Article History

Accepted: 16 November 2023

First Online: 27 November 2023

Declarations

:

: Shih-Wei Lai contributed to the conception of the article, initiated the draft of the article, and approved the final draft.

: The author declares no conflict of interest.

Document is current

Any future updates will be listed below